1
|
Grabenhenrich L, Trendelenburg V, Bellach J, Yürek S, Reich A, Fiandor A, Rivero D, Sigurdardottir S, Clausen M, Papadopoulos NG, Xepapadaki P, Sprikkelman AB, Dontje B, Roberts G, Grimshaw K, Kowalski ML, Kurowski M, Dubakiene R, Rudzeviciene O, Fernández‐Rivas M, Couch P, Versteeg SA, Ree R, Mills C, Keil T, Beyer K. Frequency of food allergy in school-aged children in eight European countries-The EuroPrevall-iFAAM birth cohort. Allergy 2020; 75:2294-2308. [PMID: 32219884 DOI: 10.1111/all.14290] [Citation(s) in RCA: 49] [Impact Index Per Article: 12.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/06/2019] [Revised: 02/25/2020] [Accepted: 02/29/2020] [Indexed: 11/28/2022]
Abstract
BACKGROUND The prevalence of food allergy (FA) among European school children is poorly defined. Estimates have commonly been based on parent-reported symptoms. We aimed to estimate the frequency of FA and sensitization against food allergens in primary school children in eight European countries. METHODS A follow-up assessment at age 6-10 years of a multicentre European birth cohort based was undertaken using an online parental questionnaire, clinical visits including structured interviews and skin prick tests (SPT). Children with suspected FA were scheduled for double-blind, placebo-controlled oral food challenges (DBPCFC). RESULTS A total of 6105 children participated in this school-age follow-up (57.8% of 10 563 recruited at birth). For 982 of 6069 children (16.2%), parents reported adverse reactions after food consumption in the online questionnaire. Of 2288 children with parental face-to-face interviews and/or skin prick testing, 238 (10.4%) were eligible for a DBPCFC. Sixty-three foods were challenge-tested in 46 children. Twenty food challenges were positive in 17 children, including seven to hazelnut and three to peanut. Another seventy-one children were estimated to suffer FA among those who were eligible but refused DBPCFC. This yielded prevalence estimates for FA in school age between 1.4% (88 related to all 6105 participants of this follow-up) and 3.8% (88 related to 2289 with completed eligibility assessment). INTERPRETATION In primary school children in eight European countries, the prevalence of FA was lower than expected even though parents of this cohort have become especially aware of allergic reactions to food. There was moderate variation between centres hampering valid regional comparisons.
Collapse
Affiliation(s)
- Linus Grabenhenrich
- Department for Methodology and Research Infrastructure Robert Koch‐Institut Berlin Germany
- Department of Dermatology, Venerology and Allergology Charité ‐ Universitätsmedizin Berlin Berlin Germany
| | - Valérie Trendelenburg
- Department of Paediatric Pneumology, Immunology and Intensive Care Charité ‐ Universitätsmedizin Berlin Berlin Germany
| | - Johanna Bellach
- Department of Paediatric Pneumology, Immunology and Intensive Care Charité ‐ Universitätsmedizin Berlin Berlin Germany
- Department of Psychiatry and Psychotherapy Ernst von Bergmann Academic Educational Hospital Berlin Germany
| | - Songül Yürek
- Department of Paediatric Pneumology, Immunology and Intensive Care Charité ‐ Universitätsmedizin Berlin Berlin Germany
| | - Andreas Reich
- Epidemiology Unit German Rheumatism Research Centera Leibniz Institute Berlin Germany
| | - Ana Fiandor
- Department of Allergy Hospital Universitario La Paz Madrid Spain
| | - Daniela Rivero
- Department of Allergy Hospital Universitario La Paz Madrid Spain
| | - Sigurveig Sigurdardottir
- Department of Immunology Landspitali University Hospital Reykjavik Iceland
- Faculty of Medicine University of Iceland Reykjavik Iceland
| | - Michael Clausen
- Faculty of Medicine University of Iceland Reykjavik Iceland
- Children's Hospital Reykjavik Reykjavik Iceland
- Department of Allergy Landspitali University Hospital Reykjavik Iceland
| | - Nikolaos G. Papadopoulos
- Division of Infection Immunity & Respiratory Medicine University of Manchester Manchester UK
- Allergy Department 2nd Paediatric Clinic, National and Kapodistrian University of Athens Athens Greece
| | - Paraskevi Xepapadaki
- Allergy Department 2nd Paediatric Clinic, National and Kapodistrian University of Athens Athens Greece
| | - Aline B. Sprikkelman
- Department of Pediatric Pulmonology & Pediatric Allergology University Medical Center Groningen Groningen The Netherlands
| | - Bianca Dontje
- Department of Pediatric Pulmonology & Pediatric Allergology Emma Kinderziekenhuis AMC Amsterdam The Netherlands
| | - Graham Roberts
- Clinical and Experimental Sciences and Human Development and Health Faculty of Medicine University of Southampton Southampton UK
- NIHR Southampton Biomedical Research Centre University Hospital Southampton NHS Foundation Trust Southampton UK
| | - Kate Grimshaw
- Clinical and Experimental Sciences Academic Units Faculty of Medicine University of Southampton Southampton UK
- Department of Dietetics Salford Care Organisation Salford UK
| | - Marek L. Kowalski
- Department of Immunology, Allergy and Rheumatology Medical University Łódź Poland
| | - Marcin Kurowski
- Department of Immunology, Allergy and Rheumatology Medical University of Łódź Łódź Poland
| | - Ruta Dubakiene
- Faculty of Medicine Vilnius University Vilnius Lithuania
| | - Odilija Rudzeviciene
- Clinic of Children's Diseases Faculty of Medicine Vilnius University Vilnius Lithuania
| | | | - Philip Couch
- School of Health Sciences Centre for Health Informatics University of Manchester Manchester UK
| | - Serge A. Versteeg
- Departments of Experimental Immunology Academic Medical Center Amsterdam The Netherlands
| | - Ronald Ree
- Departments of Experimental Immunology and of Otorhinolaryngology Amsterdam University Medical Centers Amsterdam The Netherlands
| | - Clare Mills
- Division of Infection, Immunity and Respiratory Medicine University of Manchester Manchester UK
| | - Thomas Keil
- Institute for Clinical Epidemiology and Biometry University of Würzburg Würzburg Germany
- State Institute of Health Bavarian Health and Food Safety Authority Bad Kissingen Germany
- Institute for Social Medicine, Epidemiology and Health Economics Charité ‐ Universitätsmedizin Berlin Berlin Germany
| | - Kirsten Beyer
- Department of Paediatric Pneumology, Immunology and Intensive Care Charité ‐ Universitätsmedizin Berlin Berlin Germany
| |
Collapse
|
2
|
Soto J, Soto P, Ajata A, Rivero D, Luque C, Tintaya C, Berman J. Miltefosine Combined with Intralesional Pentamidine for Leishmania braziliensis Cutaneous Leishmaniasis in Bolivia. Am J Trop Med Hyg 2019; 99:1153-1155. [PMID: 30255833 DOI: 10.4269/ajtmh.18-0183] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
Abstract
Bolivian cutaneous leishmaniasis due to Leishmania braziliensis was treated with the combination of miltefosine (150 mg/day for 28 days) plus intralesional pentamidine (120 μg/mm2 lesion area on days 1, 3, and 5). Ninety-two per cent of 50 patients cured. Comparison to historic controls at our site suggests that the efficacy of the two drugs was additive. Adverse effects and cost were also additive. This combination may be attractive when a prime consideration is efficacy (e.g., in rescue therapy), avoidance of parenteral therapy, or the desire to treat locally and also provide systemic protection against parasite dissemination.
Collapse
Affiliation(s)
- Jaime Soto
- FUNDERMA (Fundación Nacional de Dermatología), Santa Cruz, Bolivia
| | - Paula Soto
- FUNDERMA (Fundación Nacional de Dermatología), Santa Cruz, Bolivia
| | - Andrea Ajata
- Servicio Departamental de Salud, Departamento de La Paz, La Paz, Bolivia
| | - Daniela Rivero
- Hospital Dermatológico de Jorochito, Santa Cruz, Bolivia
| | - Carmelo Luque
- Servicio Departamental de Salud, Departamento de La Paz, La Paz, Bolivia
| | - Carlos Tintaya
- Servicio Departamental de Salud, Departamento de La Paz, La Paz, Bolivia
| | | |
Collapse
|
3
|
Ramírez-Morales I, Fernández-Blanco E, Rivero D, Pazos A. Automated early detection of drops in commercial egg production using neural networks. Br Poult Sci 2017; 58:739-747. [DOI: 10.1080/00071668.2017.1379051] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Affiliation(s)
- I. Ramírez-Morales
- Universidad Técnica de Machala, Faculty of Agricultural & Livestock Sciences, Machala, Ecuador
- Universidade A Coruña, Department of Computer Science, A Coruña, España
| | | | - D. Rivero
- Universidade A Coruña, Department of Computer Science, A Coruña, España
| | - A. Pazos
- Universidade A Coruña, Department of Computer Science, A Coruña, España
| |
Collapse
|
4
|
Martín-Muñoz MF, Pineda F, García Parrado G, Guillén D, Rivero D, Belver T, Quirce S. Food allergy in breastfeeding babies. Hidden allergens in human milk. Eur Ann Allergy Clin Immunol 2016; 48:123-128. [PMID: 27425167] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/06/2023]
Abstract
BACKGORUND Food allergy is a rare disorder among breastfeeding babies. OBJECTIVE Our aim was to identify responsible allergens in human milk. METHODS We studied babies developing allergic symptoms at the time they were breastfeeding. Skin prick tests (SPT) were performed with breast milk and food allergens. Specific IgE was assessed and IgE Immunoblotting experiments with breast milk were carried out to identify food allergens. Clinical evolution was evaluated after a maternal free diet. RESULTS Five babies had confirmed breast milk allergy. Peanut, white egg and/or cow's milk were demonstrated as the hidden responsible allergens. No baby returned to develop symptoms once mother started a free diet. Three of these babies showed tolerance to other food allergens identified in human milk. CONCLUSION A maternal free diet should be recommended only if food allergy is confirmed in breastfed babies.
Collapse
Affiliation(s)
- M F Martín-Muñoz
- Department of Allergy, Hospital La Paz Health Research Institute (IdiPAZ), Madrid, Spain. Phone: +34 62 649 3341 Fax: +34 727 7050 E-mail: ;
| | - F Pineda
- Diater Laboratories, R&D Department, Madrid, Spain
| | | | - D Guillén
- Department of Allergy, Hospital La Paz Health Research Institute (IdiPAZ), Madrid, Spain
| | - D Rivero
- Department of Allergy, Hospital La Paz Health Research Institute (IdiPAZ), Madrid, Spain
| | - T Belver
- Department of Allergy, Hospital La Paz Health Research Institute (IdiPAZ), Madrid, Spain
| | - S Quirce
- Department of Allergy, Hospital La Paz Health Research Institute (IdiPAZ), Madrid, Spain
| |
Collapse
|
5
|
Lam EJ, Gálvez ME, Cánovas M, Montofré IL, Rivero D, Faz A. Evaluation of metal mobility from copper mine tailings in northern Chile. Environ Sci Pollut Res Int 2016; 23:11901-11915. [PMID: 26957432 DOI: 10.1007/s11356-016-6405-y] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/19/2015] [Accepted: 03/01/2016] [Indexed: 06/05/2023]
Abstract
This work shows the results obtained on a copper mine tailing in the Antofagasta Region, Chile. The tailing was classified as saline-sodic with high concentrations of metals, especially Cu and Fe, with pH 8.4. Our objectives were to (1) compare the physicochemical properties of the tailing with surrounding soils of the mine under study, and (2) evaluate the effect of two amendments (CaCO3 and compost) and their mixtures on Cu(2+), Mn, Fe, Zn, Mg(2+), and K(+) and Ca(2+), SO4 (2-), NO3 (-), and PO4 (3-) leaching. The data obtained were submitted to variance and covariance analysis. The results from the comparison between both substrates showed that in general, the tailing presented greater content of metals. Regarding tailing leaching, pH, electrical conductivity (EC), and concentration of the elements of interest were measured. The statistical analysis showed that Cu(2+) leaching and immobilization of Fe occurred to the greatest extent with compost. The EC decreased throughout the experiment with irrigation and increased upon treatment with compost. The major interactions found among the chemical parameters were (1) tailings without treatment, Cu(2+)/Fe and NO3 (-)/SO4 (2-); (2) tailings treated with CaCO3, Cu(2+)/K(+); (3) tailings treated with compost, NO3 (-)/SO4 (-2) and EC/Cu(2+); and (4) tailings treated with both amendments, EC/Fe and Cu(2+)/Fe. The ANOVA showed that the number of irrigations and the amendments statistically significantly affected the copper mobility and the organic amendment significantly influenced the iron mobility.
Collapse
Affiliation(s)
- Elizabeth J Lam
- Chemical Engineering Department, Universidad Católica del Norte, Antofagasta, Chile.
| | - M E Gálvez
- Chemical Engineering Department, Universidad Católica del Norte, Antofagasta, Chile
| | - M Cánovas
- Metallurgical and Mining Engineering Department, Universidad Católica del Norte, Avda. Angamos 0610, Antofagasta, Chile
| | - I L Montofré
- Chemical Engineering Department, Universidad Católica del Norte, Antofagasta, Chile
| | - D Rivero
- Chemical Engineering Department, Universidad Católica del Norte, Antofagasta, Chile
| | - A Faz
- Agrarian Science and Technology Department, Universidad Politécnica de Cartagena, Paseo Alfonso XIII 48, 30203, Cartagena, Spain
| |
Collapse
|
6
|
Soto J, Paz D, Rivero D, Soto P, Quispe J, Toledo J, Berman J. Intralesional Pentamidine: A Novel Therapy for Single Lesions of Bolivian Cutaneous Leishmaniasis. Am J Trop Med Hyg 2016; 94:852-6. [PMID: 26903605 DOI: 10.4269/ajtmh.15-0640] [Citation(s) in RCA: 29] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/02/2015] [Accepted: 12/21/2015] [Indexed: 11/07/2022] Open
Abstract
A novel therapy, intralesional (IL) pentamidine, was compared to intralesional therapy with antimony (ILSb), a World Health Organization-recommended therapy, for single Bolivian Leishmania braziliensis lesions. In Study 1, 90 patients were randomized equally between three injections of ILSb over 5 days, five injections of ILSb over 11 days, and three injections of IL pentamidine (120 μg/mm(2)lesion area [ILPenta-120-3]) over 5 days. Cure rates at 6 months were 57% for ILSb-3 injections, 73% for ILSb-5 injections, and 72% for ILPenta-120-3 injections. Adverse effects were local irritation and injection-site pain-ILSb (60 patients): mild (25), moderate (4); IL pentamidine (30 patients): mild (4), moderate (3). In Study 2, 60 patients were randomized equally between five injections of ILSb and three injections of a double dose of IL pentamidine (240 μg/mm(2)[ILPenta-240-3]). In Study 2, cure rates were 67% for ILSb-5 injections and 73% for ILPenta-240-3. For three IL injections of pentamidine, efficacy was optimized at a dose of 120 μg/mm(2)lesion area. The cure rate of that regimen was similar to that for ILSb-5 injections and nonstatistically larger than that of ILSb-3 injections. IL pentamidine is an attractive alternative to ILSb on the basis of efficacy for Bolivian L. braziliensis, the threat of Sb-resistant parasites, tolerance, and patient convenience of three visits over 5 days.
Collapse
Affiliation(s)
- Jaime Soto
- Fundación Nacional de Dermatología (FUNDERMA), Santa Cruz, Bolivia; Hospital Dermatológico de Jorochito, Santa Cruz, Bolivia; Hospital Local, Palos Blancos, Bolivia; Centro de Investigaciones Bioclínicas de la Fundación Fader (FADER-CIBIC), Bogota, Colombia; AB Foundation, North Bethesda, Maryland
| | - David Paz
- Fundación Nacional de Dermatología (FUNDERMA), Santa Cruz, Bolivia; Hospital Dermatológico de Jorochito, Santa Cruz, Bolivia; Hospital Local, Palos Blancos, Bolivia; Centro de Investigaciones Bioclínicas de la Fundación Fader (FADER-CIBIC), Bogota, Colombia; AB Foundation, North Bethesda, Maryland
| | - Daniela Rivero
- Fundación Nacional de Dermatología (FUNDERMA), Santa Cruz, Bolivia; Hospital Dermatológico de Jorochito, Santa Cruz, Bolivia; Hospital Local, Palos Blancos, Bolivia; Centro de Investigaciones Bioclínicas de la Fundación Fader (FADER-CIBIC), Bogota, Colombia; AB Foundation, North Bethesda, Maryland
| | - Paula Soto
- Fundación Nacional de Dermatología (FUNDERMA), Santa Cruz, Bolivia; Hospital Dermatológico de Jorochito, Santa Cruz, Bolivia; Hospital Local, Palos Blancos, Bolivia; Centro de Investigaciones Bioclínicas de la Fundación Fader (FADER-CIBIC), Bogota, Colombia; AB Foundation, North Bethesda, Maryland
| | - Jorge Quispe
- Fundación Nacional de Dermatología (FUNDERMA), Santa Cruz, Bolivia; Hospital Dermatológico de Jorochito, Santa Cruz, Bolivia; Hospital Local, Palos Blancos, Bolivia; Centro de Investigaciones Bioclínicas de la Fundación Fader (FADER-CIBIC), Bogota, Colombia; AB Foundation, North Bethesda, Maryland
| | - Julia Toledo
- Fundación Nacional de Dermatología (FUNDERMA), Santa Cruz, Bolivia; Hospital Dermatológico de Jorochito, Santa Cruz, Bolivia; Hospital Local, Palos Blancos, Bolivia; Centro de Investigaciones Bioclínicas de la Fundación Fader (FADER-CIBIC), Bogota, Colombia; AB Foundation, North Bethesda, Maryland
| | - Jonathan Berman
- Fundación Nacional de Dermatología (FUNDERMA), Santa Cruz, Bolivia; Hospital Dermatológico de Jorochito, Santa Cruz, Bolivia; Hospital Local, Palos Blancos, Bolivia; Centro de Investigaciones Bioclínicas de la Fundación Fader (FADER-CIBIC), Bogota, Colombia; AB Foundation, North Bethesda, Maryland
| |
Collapse
|
7
|
Affiliation(s)
- M F Martín-Muñoz
- Allergy Department, Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain.
| | - D Rivero
- Allergy Department, Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain
| | - A Díaz Perales
- Centro de Biotecnologia y Genómica de Plantas (UPM-INIA), Madrid, Spain
| | - I Polanco
- Pediatric Department, Hospital La Paz Instituto de Investigación (idiPaz), Madrid, Spain
| | - S Quirce
- Allergy Department, Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain
| |
Collapse
|
8
|
Ramírez E, Tong HY, Fiandor A, Martín-Hervás C, Rivero D, Oñate M, Rueda C, Cabañas R, Moro M, Tapia M, Fernández A, Morón S, Herrero A, Garzón G, Quirce S, Frías J. Hypersensitivity reactions to contrast media injections: a nested case-control study. Ann Allergy Asthma Immunol 2014; 113:488-9.e5. [PMID: 25155086 DOI: 10.1016/j.anai.2014.07.016] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/18/2014] [Revised: 07/14/2014] [Accepted: 07/15/2014] [Indexed: 12/27/2022]
Affiliation(s)
- Elena Ramírez
- Department of Clinical Pharmacology, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain; School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain.
| | - Hoi Y Tong
- Department of Clinical Pharmacology, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain
| | - Ana Fiandor
- Department of Allergy, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain
| | | | - Daniela Rivero
- Department of Allergy, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain
| | - Marta Oñate
- Department of Radiology, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain
| | - Cristina Rueda
- Department of Pharmacy, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain
| | - Rosario Cabañas
- Department of Allergy, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain
| | - Marta Moro
- Department of Pharmacy, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain
| | - Mar Tapia
- Department of Radiology, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain
| | - Amelia Fernández
- Department of Radiology, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain
| | - Sara Morón
- Department of Radiology, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain
| | - Alicia Herrero
- Department of Pharmacy, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain
| | - Gonzalo Garzón
- Department of Radiology, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain
| | - Santiago Quirce
- Department of Allergy, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain
| | - Jesús Frías
- Department of Clinical Pharmacology, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain
| |
Collapse
|
9
|
Mallet A, Kypriotou M, George K, Leclerc E, Rivero D, Mazereeuw-Hautier J, Serre G, Huber M, Jonca N, Hohl D. Identification of the first nonsenseCDSNmutation with expression of a truncated protein causing peeling skin syndrome type B. Br J Dermatol 2013; 169:1322-5. [DOI: 10.1111/bjd.12593] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 08/13/2013] [Indexed: 02/04/2023]
Affiliation(s)
- A. Mallet
- UMR 5165/U1056 ‘Unité de Différenciation Epidermique et Autoimmunité Rhumatoïde’ (CNRS, INSERM Université Toulouse III CHU de Toulouse); Hôpital Purpan; Place du Dr Baylac; TSA 40031; 31059 Toulouse CEDEX 9 France
| | - M. Kypriotou
- Laboratory of Cutaneous Biology; Service of Dermatology and Venereology; Beaumont Hospital CHUV; Beaumont Avenue 29 1011 Lausanne Switzerland
| | - K. George
- Laboratory of Cutaneous Biology; Service of Dermatology and Venereology; Beaumont Hospital CHUV; Beaumont Avenue 29 1011 Lausanne Switzerland
| | - E. Leclerc
- UMR 5165/U1056 ‘Unité de Différenciation Epidermique et Autoimmunité Rhumatoïde’ (CNRS, INSERM Université Toulouse III CHU de Toulouse); Hôpital Purpan; Place du Dr Baylac; TSA 40031; 31059 Toulouse CEDEX 9 France
| | - D. Rivero
- Laboratory of Cutaneous Biology; Service of Dermatology and Venereology; Beaumont Hospital CHUV; Beaumont Avenue 29 1011 Lausanne Switzerland
| | - J. Mazereeuw-Hautier
- UMR 5165/U1056 ‘Unité de Différenciation Epidermique et Autoimmunité Rhumatoïde’ (CNRS, INSERM Université Toulouse III CHU de Toulouse); Hôpital Purpan; Place du Dr Baylac; TSA 40031; 31059 Toulouse CEDEX 9 France
| | - G. Serre
- UMR 5165/U1056 ‘Unité de Différenciation Epidermique et Autoimmunité Rhumatoïde’ (CNRS, INSERM Université Toulouse III CHU de Toulouse); Hôpital Purpan; Place du Dr Baylac; TSA 40031; 31059 Toulouse CEDEX 9 France
| | - M. Huber
- Laboratory of Cutaneous Biology; Service of Dermatology and Venereology; Beaumont Hospital CHUV; Beaumont Avenue 29 1011 Lausanne Switzerland
| | - N. Jonca
- UMR 5165/U1056 ‘Unité de Différenciation Epidermique et Autoimmunité Rhumatoïde’ (CNRS, INSERM Université Toulouse III CHU de Toulouse); Hôpital Purpan; Place du Dr Baylac; TSA 40031; 31059 Toulouse CEDEX 9 France
| | - D. Hohl
- Laboratory of Cutaneous Biology; Service of Dermatology and Venereology; Beaumont Hospital CHUV; Beaumont Avenue 29 1011 Lausanne Switzerland
| |
Collapse
|
10
|
Tuneu MJ, Vallès X, Carnicer-Pont D, Barberá MJ, Godoy P, Avecilla-Palau A, Jordà B, Lopez-Grado E, Rivero D, Vives A, Acera A, Almirall R, Crespo N, Casabona J, the Partner Notification Study Group C. Pilot study to introduce a notification card for partner notification of sexually transmitted infections in Catalonia, Spain, June 2010 to June 2011. Euro Surveill 2013; 18. [DOI: 10.2807/1560-7917.es2013.18.27.20516] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
We conducted a cross-sectional study in 10 primary care centres in Catalonia, to determine applicability, acceptability and effectiveness of partner notification cards used by patients diagnosed of a sexually transmitted infection (STI) and to characterise these and their sexual partners. Statutorily notifiable STIs included Chlamydia infection, gonorrhoea, syphilis, human immunodeficiency virus (HIV) infection or other STIs as deemed necessary by the treating physician. Between June 2010 and June 2011, 219 index cases were enrolled, of whom 130 were men (59.4%), 71 of them men who have sex with men (54.6%). Chlamydia infection (41.1%), gonorrhoea (17.8%) and syphilis (16.0%) were the STIs most frequently diagnosed. HIV infection accounted for 4% of cases. A total of 687 sexual partners were reported, and 300 of these were traceable through the notification card (45.7%). Those who did not report traceable contacts were older (mean age: 34 years versus 31 years, p=0.03). The main reason for not distributing the card was anonymous sexual intercourse (38%). Patient referral notification cards can reach a high percentage of sexual partners at risk. However, only few notified sexual partners attended participating health centres. Internet-based partner notification may be considered in order to reach those partners not otherwise traceable.
Collapse
Affiliation(s)
- M J Tuneu
- Pompeu Fabra University, Barcelona, Spain
- Centre for Epidemiological Studies on Sexually Transmitted Infections and HIV/AIDS of Catalonia (CEEISCAT), Catalan Institute of Oncology (ICO), Public Health Agency of Catalonia (ASPCAT), Barcelona, Spain
| | - X Vallès
- Centre for Epidemiological Studies on Sexually Transmitted Infections and HIV/AIDS of Catalonia (CEEISCAT), Catalan Institute of Oncology (ICO), Public Health Agency of Catalonia (ASPCAT), Barcelona, Spain
| | - D Carnicer-Pont
- Centros de Investigación Biomédica en Red Epidemiología y Salud Pública (CIBERESP), Spain
- Department of Paediatrics, Obstetrics, Gynaecology and Public Health of the Autonomous University of Barcelona, Bellaterra, Barcelona, Spain
- Centre for Epidemiological Studies on Sexually Transmitted Infections and HIV/AIDS of Catalonia (CEEISCAT), Catalan Institute of Oncology (ICO), Public Health Agency of Catalonia (ASPCAT), Barcelona, Spain
| | - M J Barberá
- Sexually Transmitted Infections Unit, Drassanes Primary Health Centre, Catalan Institute of Health, Barcelona, Spain
| | - P Godoy
- Epidemiological Surveillance Unit, Lleida, Spain
- Centros de Investigación Biomédica en Red Epidemiología y Salud Pública (CIBERESP), Spain
| | - A Avecilla-Palau
- Care Programme for sexual and reproductive health, Badalona Care Services, Barcelona, Spain
| | - B Jordà
- Care programme for sexual and reproductive health, Catalan Institute of Health, Barcelona, Spain
| | - E Lopez-Grado
- Care programme for sexual and reproductive health, Catalan Institute of Health, Sabadell, Spain
| | - D Rivero
- Salt Primary Health Centre, Catalan Institute of Health, Girona, Spain
| | - A Vives
- Department of Andrology, Puigvert Foundation, Barcelona, Spain
| | - A Acera
- Sexually Transmitted Infections Unit, Cerdanyola Primary Health Centre, Catalan Institute of Health, Barcelona, Spain
| | - R Almirall
- Care programme for sexual and reproductive health, Catalan Institute of Health, Esquerra de l’Eixample, Barcelona, Spain
| | - N Crespo
- Care programme for sexual and reproductive health, Catalan Institute of Health, Manresa, Barcelona, Spain
| | - J Casabona
- Centros de Investigación Biomédica en Red Epidemiología y Salud Pública (CIBERESP), Spain
- Department of Paediatrics, Obstetrics, Gynaecology and Public Health of the Autonomous University of Barcelona, Bellaterra, Barcelona, Spain
- Centre for Epidemiological Studies on Sexually Transmitted Infections and HIV/AIDS of Catalonia (CEEISCAT), Catalan Institute of Oncology (ICO), Public Health Agency of Catalonia (ASPCAT), Barcelona, Spain
| | | |
Collapse
|
11
|
Valdés-Infante J, Rodríguez N, Velásquez B, Rivero D, Martínez F, Espinosa G, Risterucci A, Billotte N, Becker D, Rohde W. SIMPLE SEQUENCE REPEATS (SSRS) FOR DIVERSITY CHARACTERIZATION OF GUAVA (PSIDIUM GUAJAVA L.). ACTA ACUST UNITED AC 2010. [DOI: 10.17660/actahortic.2010.849.17] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
12
|
Castel MA, Vallejos I, Ramos P, Arias A, Bravo C, Ferrero M, Rivero D, Sionis A, Pérez-Villa F, Roig E. Outcome after steroid withdrawal in heart transplantation. Transplant Proc 2009; 41:2253-5. [PMID: 19715890 DOI: 10.1016/j.transproceed.2009.06.028] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Abstract
BACKGROUND There is a lack of consensus and insufficient data to assess the impact of late steroid withdrawal after heart transplantation (HTx). The aim of the study was to investigate the security and feasibility of corticosteroid withdrawal at 1 year after transplantation. METHODS AND RESULTS Steroid withdrawal was attempted after at least 12 months of treatment in 86 HTx patients who fulfilled the criteria. At 1 and 3 months after drug discontinuation, patients underwent 2 endomyocardial biopsies (EMB). After a mean follow-up of 25 +/- 13 months, 63% of the patients remained steroid free. In 30 patients (35%) corticosteroids were reinitiated, in 15 cases because of acute rejection (7%), 5 (6%) because of worsening renal function, 5 (6%) because of malignancy, 3 (4%) because of adverse effects of immunosuppressive drugs, and 2 because of severe allograft coronary artery disease. Four patients (5%) died after drug discontinuation. There was a significant decrease in total cholesterol (198 +/- 35 to 181 +/- 38 mg/dL; P < .001) and low-density lipoprotain (LDL) cholesterol levels (113 +/- 30 to 105 +/- 30 mg/dL; P < .001). There were no differences in mortality between patients with and without corticosteroids. CONCLUSION Steroid withdrawal is feasible and safe in HTx patients. In our study, it was successfully maintained in 63% of the patients. EMB is helpful to identify patients with acute rejection at 1 and 3 months after withdrawal. Short- to mid-term metabolic benefits are significant reductions in serum total and LDL cholesterol.
Collapse
Affiliation(s)
- M A Castel
- Thorax Clinic Institute, Hospital Clinic, University of Barcelona, Barcelona, Spain.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
13
|
Gonzalez-Moneo MJ, Simó M, Pie M, Rivero D. Preferences of general practitioners and carers of Alzheimer patients regarding the use of neuroleptics for behavioural disorders in Alzheimer's disease. Int J Geriatr Psychiatry 2008; 23:1095-7. [PMID: 18613282 DOI: 10.1002/gps.2011] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
14
|
Abstract
BACKGROUND The amount of limb-length discrepancy necessary to adversely affect gait parameters in older adults is unknown, with information being largely anecdotal. This investigation was conducted to determine the effects of limb-length discrepancy on gait economy and lower-extremity muscle activity in older adults. METHODS Forty-four men and women ranging in age from fifty-five to eighty-six years with no evidence of limb-length discrepancy of >1 cm participated in the study. Subjects walked on a treadmill at a self-selected normal walking pace with artificial limb-length discrepancies of 0, 2, 3, and 4 cm applied in a randomly selected order. Indirect calorimetry was used to measure oxygen consumption and minute ventilation. Electromyography was used to measure muscle activity of the right and left quadriceps femoris, plantar flexors, gluteus maximus, and gluteus medius. Heart rate, the rating of perceived exertion, and frequency of gait compensation patterns were also measured. RESULTS There was a significant increase in oxygen consumption and the rating of perceived exertion with 2, 3, and 4-cm artificial limb-length discrepancies; a significant increase in heart rate, minute ventilation, and quadriceps activity in the longer limb with 3 and 4-cm artificial limb-length discrepancies; and a significant increase in plantar flexor activity in the shorter limb with a 4-cm artificial limb-length discrepancy compared with the same parameters with no artificial limb-length discrepancy. CONCLUSIONS Both oxygen consumption and the rating of perceived exertion were greater with a 2-cm artificial limb-length discrepancy than they were with no artificial limb-length discrepancy. There appears to be a breakpoint between 2 and 3 cm of artificial limb-length discrepancy in older adults with regard to the effects on most other physiological parameters. A 3-cm artificial limb-length discrepancy is likely to induce significant quadriceps fatigue in the longer limb. Elderly patients with substantial pulmonary, cardiac, or neuromuscular disease may have difficulty walking with a limb-length discrepancy as small as 2 cm.
Collapse
Affiliation(s)
- B Gurney
- Division of Physical Therapy, University of New Mexico, Albuquerque 87131-5661, USA.
| | | | | | | | | |
Collapse
|
15
|
Eiras J, Cantero J, Fernández D, Alberdi J, Gómez J, Fraile J, Rivero D. 4. Craniotomía órbito-zigomática en el tratamiento de neurinomas de trigémino. Neurocirugia (Astur) 2001. [DOI: 10.1016/s1130-1473(01)70795-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
16
|
Gurney AB, Mermier C, Rivero D, Gibson A. EFFECTS OF LEG LENGTH DISCREPANCY ON GAIT ECONOMY AND LOWER EXTREMITY MUSCLE ACTIVITY IN OLDER ADULTS. J Geriatr Phys Ther 2001. [DOI: 10.1519/00139143-200124010-00023] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
|
17
|
Abstract
Heterotopic ossification is a well-recognized condition frequently encountered by the orthopedic surgeon. Although typically asymptomatic, heterotopic ossification can be a complication of extreme severity. This article is a review of literature and attempts to clarify the definition, and delineates the etiology, incidence, risk factors, and current modes of prophylaxis and treatment of various types of heterotopic ossification.
Collapse
Affiliation(s)
- F F Naraghi
- Department of Orthopedics & Rehabilitation, University of New Mexico, Albuquerque, USA
| | | | | | | | | |
Collapse
|
18
|
Rivero D, DeCoster TA. Total hip arthroplasty--a cure? West J Med 1995; 162:274. [PMID: 7725723 PMCID: PMC1022726] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]
|
19
|
Rodríguez P, Fuentes D, Muñoz E, Rivero D, Orta D, Alburquerque S, Perez S, Besada V, Herrera L. The streptokinase domain responsible for plasminogen binding. ACTA ACUST UNITED AC 1994. [DOI: 10.1016/0268-9499(94)90016-7] [Citation(s) in RCA: 20] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
20
|
Hadler SC, Alcala de Monzon M, Rivero D, Perez M, Bracho A, Fields H. Epidemiology and long-term consequences of hepatitis delta virus infection in the Yucpa Indians of Venezuela. Am J Epidemiol 1992; 136:1507-16. [PMID: 1288280 DOI: 10.1093/oxfordjournals.aje.a116472] [Citation(s) in RCA: 24] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022] Open
Abstract
To define better the epidemiology and clinical impact of hepatitis delta virus (HDV) infection among hepatitis B virus (HBV) carriers in less developed countries, the authors prospectively studied a cohort of 216 Yucpa Indian HBV carriers in Venezuela. HBV carriers were followed regularly between 1983 and 1988 by physical examination, laboratory testing for liver enzymes and HBV and HDV markers, and epidemiologic history. Among the cohort, 74 (34%) were initially positive for HDV infection, and 35 additional persons became infected during the study. Risk factors for new HDV infection included living in southern Yucpa villages; being young adults (15-19 years) or young children (1-9 years), and living in a household with a person with acute HDV infection. Persons with HDV infection were at high risk of developing chronic liver disease; 56% of HDV-infected persons had moderate-to-severe chronic liver disease at the end of the study compared with none of the HBV carriers without HDV infection. Mortality rates were 6.9% and 8.8% per year, respectively, among initially HDV-positive HBV carriers and those with new HDV infection, because of rapidly progressive chronic liver disease and fulminant hepatitis; mortality was significantly lower in HBV carriers without HDV infection and in non-HBV carriers. HDV superinfection is a devastating disease in HBV carriers in tropical South America. Prevention of HBV infection with hepatitis B vaccine is the best available tool to reduce the impact of this problem.
Collapse
Affiliation(s)
- S C Hadler
- Surveillance, Investigations, and Research Branch, Centers for Disease Control, Atlanta, GA 30333
| | | | | | | | | | | |
Collapse
|
21
|
Fernández Barboza R, Rivero D, Echeverría B, Machado IV. [Cost-benefits of vaccination against hepatitis B in hospital personnel in Venezuela]. Bol Oficina Sanit Panam 1991; 111:16-23. [PMID: 1834080] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
Abstract
A cost-benefit study for hepatitis B vaccination in Venezuelan hospital workers was performed through a decision tree analysis model, which includes the probabilities for the different outcomes of the hepatitis B virus infection (HBV). The current average cost of HBV infection to the Venezuelan Government was estimated at US$ 1,759 per patient. Implementation of selective vaccination or a mass vaccination campaign for the hospital workers would reduce the total cost of HBV infection to 51% or 28%, respectively, saving $17 to $26 million. This type of economic analysis may influence the distribution of the resources to be allocated for the control of HBV infection in Venezuela.
Collapse
Affiliation(s)
- R Fernández Barboza
- Ministerio de Sanidad y Asistencia Social de Venezuela, Departamento de Vigilancia Epidemiológica, Caracas
| | | | | | | |
Collapse
|
22
|
Masur SK, Sapirstein V, Rivero D. Phorbol myristate acetate induces endocytosis as well as exocytosis and hydroosmosis in toad urinary bladder. Biochim Biophys Acta 1985; 821:286-96. [PMID: 3933562 DOI: 10.1016/0005-2736(85)90098-7] [Citation(s) in RCA: 24] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]
Abstract
The induction of the hydroosmotic response in the toad urinary bladder is considered to be associated with membrane addition mediated by exocytosis at the affected luminal membrane and reversed by endocytic retrieval at that surface. The permeability, exocytosis and endocytosis are initiated by antidiuretic hormone (ADH) receptor interaction on the basolateral membrane. In other hormone responsive systems, phorbol ester (phorbol myristate acetate, PMA), a tumor promoter, has been implicated in the regulation of various transport processes through the activation of protein kinase C and cytoskeletal protein phosphorylation. We found that addition of 10(-6) M PMA to the mucosa induces an hydroosmotic response which is gradual and which reaches a maximum within 60 min, equal to about 1/3 the maximal ADH response. Morphologically, PMA causes rapid exocytosis of the granules, endocytosis of horseradish peroxidase from the mucosal medium into tubules and multivesicular bodies and elongation of apical microvilli. Controls treated with mucosal 0.1% dimethylsulfoxide (DMSO) or an inactive PMA isomer on the mucosal surface, or PMA on the serosal surface lack the hydroosmotic, exocytic, endocytic and cytoskeletal changes. Addition of serosal ADH to PMA-treated bladders results in a precocious hydroosmotic and exocytic ADH response, but a lowering of the maximal response. Also pretreatment of bladders with PMA prevented the ADH-induced increase in transepithelial potential difference. Thus, apical events mediating the PMA hydroosmotic response are correlated with exo- and endocytosis and elongation of apical microvilli.
Collapse
|
23
|
Hadler SC, De Monzon M, Ponzetto A, Anzola E, Rivero D, Mondolfi A, Bracho A, Francis DP, Gerber MA, Thung S. Delta virus infection and severe hepatitis. An epidemic in the Yucpa Indians of Venezuela. Ann Intern Med 1984; 100:339-44. [PMID: 6696355 DOI: 10.7326/0003-4819-100-3-339] [Citation(s) in RCA: 175] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/21/2023] Open
Abstract
Over a 3-year period, 149 Yucpa Indians in Venezuela developed hepatitis; 34 persons died and at least 22 developed chronic hepatitis. Children and young adults were primarily affected, especially males. Serologic testing showed that hepatitis B virus infection was highly endemic in this population, but also that 65% of patients had hepatitis B virus surface antigen (HBsAg) during or after illness. Most patients had evidence of delta-agent superinfection; 86% of HBsAg-positive patients had delta antibody, and delta antigen was found in specimens taken during autopsies on 7 of 9 patients. Serologic data suggested that most infections were due to delta superinfection of hepatitis B carriers, and that more than 60% of these infections progressed to chronic disease. Delta agent infection, and particularly delta superinfection of hepatitis B carriers, appears to be an ominous occurrence that may develop in populations among whom hepatitis B virus infection is endemic, and who have no other risk factor for delta infection.
Collapse
|